Company news
Evotec Se (XETR:EVT) news
Every Evotec Se press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
August 6, 2026
Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management
July 23, 2026
Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
July 13, 2026
Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics
June 30, 2026
Evotec : Presence and Voting Results AGM 2026 68.764 KB (EVT Abstimmung Liste EN)
June 12, 2026
Evotec Reports Results of the Annual General Meeting 2026
June 11, 2026
Evotec Appoints Rui Wang as Head of Global In Silico and AI
June 2, 2026
Evotec : Letter of the Chair of Supervisory Board to the Shareholders of Evotec 116,952 KB
May 26, 2026
Evotec SE: Dr. Cord Dohrmann, sell
May 22, 2026
Evotec SE Successfully Placed €116.1 Million Convertible Bonds
May 12, 2026
Evotec SE launches approximately EUR 125 million convertible bond offering
May 12, 2026
Evotec Announces First Quarter 2026 Results: Building Transformation Momentum
May 6, 2026
Evotec SE: Paul Hitchin, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system.
May 5, 2026
Evotec SE: Aurélie Dalbiez, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration sy...
May 5, 2026
Evotec SE: Dr. Christian Wojczewski, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remune...
May 5, 2026
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
January 8, 2026
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
January 2, 2026
Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz
December 8, 2025
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
December 4, 2025
Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership
November 12, 2025
Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities
November 5, 2025
In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties
November 4, 2025
Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025
October 29, 2025
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
October 27, 2025
Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution
August 13, 2025
Evotec SE to announce first half-year results 2025 on 13 August 2025
August 6, 2025
Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site
July 30, 2025
Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site
July 30, 2025
Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix
July 21, 2025
Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance
July 21, 2025
Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury
June 25, 2025
Evotec SE: Results of the Annual General Meeting 2025
June 3, 2025
Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments
May 7, 2025
Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment
May 6, 2025
Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025
April 29, 2025
Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb
April 24, 2025
Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results
April 17, 2025
Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025
April 10, 2025
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
March 4, 2025
Evotec Announces Change in Management Board
February 26, 2025